{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:5720"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:5720","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Role of MAPK and NF-κB signalling pathways in the regulation of the human GM-CSF gene in normal and leukaemic blood cells","abstract":"GM-CSF is an important haematopoietic growth factor and immune modulator. Studies on T cells revealed that efficient activation of the human GM-CSF gene is dependent upon the activation of an enhancer located 3 kb upstream of the promoter, inducible by phorbol myristate acetate and calcium ionophore (PMNI) via kinase-and Ca\\(^2\\)\\(^+\\) -dependent signalling pathways, respectively. This enhancer is often aberrantly remodelled as a constitutive DNase hypersensitive site (DHS) in acute myeloid leukaemia (AML). To investigate the role of MAPKs in enhancer activity and chromatin remodelling, I used activated T blasts and human leukaemic cell lines as inducible model systems. The combination of MEK and p38 MAPK inhibitors reduced PMNI-induced GM-CSF gene expression and the DHS at the enhancer. This was associated with a reduction in DNA-binding activity for the MAPK-inducible AP-1 and in the phosphorylation of MSK1, which in turn stimulates NF-κB transcriptional activity by phosphorylating p65 at Ser276. The combination of MEK and p38 inhibitors also reduced the PMNI-mediated recruitment of AP-1, MSK1 and NF-κB at the enhancer. These data demonstrate a cross-talk between the MAPK and NF-κB signalling pathways in regulating GM-CSF gene transcription and therefore represent potential targets for the treatment of AML cases where aberrant chromatin remodelling occurs.","abstract_html":"GM-CSF is an important haematopoietic growth factor and immune modulator. Studies on T cells revealed that efficient activation of the human GM-CSF gene is dependent upon the activation of an enhancer located 3 kb upstream of the promoter, inducible by phorbol myristate acetate and calcium ionophore (PMNI) via kinase-and Ca<span class=\"etd-inline-math\"><sup>2</sup></span><span class=\"etd-inline-math\"><sup>+</sup></span> -dependent signalling pathways, respectively. This enhancer is often aberrantly remodelled as a constitutive DNase hypersensitive site (DHS) in acute myeloid leukaemia (AML). To investigate the role of MAPKs in enhancer activity and chromatin remodelling, I used activated T blasts and human leukaemic cell lines as inducible model systems. The combination of MEK and p38 MAPK inhibitors reduced PMNI-induced GM-CSF gene expression and the DHS at the enhancer. This was associated with a reduction in DNA-binding activity for the MAPK-inducible AP-1 and in the phosphorylation of MSK1, which in turn stimulates NF-κB transcriptional activity by phosphorylating p65 at Ser276. The combination of MEK and p38 inhibitors also reduced the PMNI-mediated recruitment of AP-1, MSK1 and NF-κB at the enhancer. These data demonstrate a cross-talk between the MAPK and NF-κB signalling pathways in regulating GM-CSF gene transcription and therefore represent potential targets for the treatment of AML cases where aberrant chromatin remodelling occurs.","abstract_has_math":true,"creators":["Canestraro, Martina"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-07","date_published":"2015-07","updated_at":"2026-11-19T09:28:34Z","subjects":["QR Microbiology","R Medicine (General)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/5720/1/Canestraro15PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A5720","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Canestraro, Martina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-07"]},{"key":"dc:date.issued","label":"Date","values":["2015-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","School of Immunity and Infection"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/5720/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR Microbiology","R Medicine (General)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/5720/1/Canestraro15PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5720/2/Decl_IS_Canestraro15PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["GM-CSF is an important haematopoietic growth factor and immune modulator. Studies on T cells revealed that efficient activation of the human GM-CSF gene is dependent upon the activation of an enhancer located 3 kb upstream of the promoter, inducible by phorbol myristate acetate and calcium ionophore (PMNI) via kinase-and Ca\\(^2\\)\\(^+\\) -dependent signalling pathways, respectively. This enhancer is often aberrantly remodelled as a constitutive DNase hypersensitive site (DHS) in acute myeloid leukaemia (AML). To investigate the role of MAPKs in enhancer activity and chromatin remodelling, I used activated T blasts and human leukaemic cell lines as inducible model systems. The combination of MEK and p38 MAPK inhibitors reduced PMNI-induced GM-CSF gene expression and the DHS at the enhancer. This was associated with a reduction in DNA-binding activity for the MAPK-inducible AP-1 and in the phosphorylation of MSK1, which in turn stimulates NF-κB transcriptional activity by phosphorylating p65 at Ser276. The combination of MEK and p38 inhibitors also reduced the PMNI-mediated recruitment of AP-1, MSK1 and NF-κB at the enhancer. These data demonstrate a cross-talk between the MAPK and NF-κB signalling pathways in regulating GM-CSF gene transcription and therefore represent potential targets for the treatment of AML cases where aberrant chromatin remodelling occurs."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Role of MAPK and NF-κB signalling pathways in the regulation of the human GM-CSF gene in normal and leukaemic blood cells"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Canestraro, Martina"],"dc:date":["2015-07"],"dc:date.issued":["2015-07"],"dc:description.abstract":["GM-CSF is an important haematopoietic growth factor and immune modulator. Studies on T cells revealed that efficient activation of the human GM-CSF gene is dependent upon the activation of an enhancer located 3 kb upstream of the promoter, inducible by phorbol myristate acetate and calcium ionophore (PMNI) via kinase-and Ca\\(^2\\)\\(^+\\) -dependent signalling pathways, respectively. This enhancer is often aberrantly remodelled as a constitutive DNase hypersensitive site (DHS) in acute myeloid leukaemia (AML). To investigate the role of MAPKs in enhancer activity and chromatin remodelling, I used activated T blasts and human leukaemic cell lines as inducible model systems. The combination of MEK and p38 MAPK inhibitors reduced PMNI-induced GM-CSF gene expression and the DHS at the enhancer. This was associated with a reduction in DNA-binding activity for the MAPK-inducible AP-1 and in the phosphorylation of MSK1, which in turn stimulates NF-κB transcriptional activity by phosphorylating p65 at Ser276. The combination of MEK and p38 inhibitors also reduced the PMNI-mediated recruitment of AP-1, MSK1 and NF-κB at the enhancer. These data demonstrate a cross-talk between the MAPK and NF-κB signalling pathways in regulating GM-CSF gene transcription and therefore represent potential targets for the treatment of AML cases where aberrant chromatin remodelling occurs."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/5720/1/Canestraro15PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5720/2/Decl_IS_Canestraro15PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","School of Immunity and Infection"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/5720/"],"dc:subject":["QR Microbiology","R Medicine (General)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Role of MAPK and NF-κB signalling pathways in the regulation of the human GM-CSF gene in normal and leukaemic blood cells"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:28:34Z"}